ReviewOncoTargets and therapy2021

Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib.

Ankit Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.